Found 1293 matching trials
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors PHASE2 Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer PHASE1 This phase I trial studies the side effects and best dose of stereotactic b...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer PHASE2 In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer NA Lung cancer remains the most frequent cause of cancer death in both men and...
Show More Location
Community Regional Medical Center
Learn More & Join Trial
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System NA The goals of this clinical research are to evaluate the outcomes and tumor ...
Show More Location
UPMC Shadyside Radiation Oncology Department
Learn More & Join Trial
Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer PHASE1 Study to determine the best dose of stereotactic body radiation therapy (SB...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC PHASE2 According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC PHASE2 This open-label, multicenter, randomized phase II study will evaluate the u...
Show More Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Learn More & Join Trial
SBRT-based PArtial Tumor Irradiation of HYpoxic Segment PHASE1 This study uses an unconventional radiotherapy schedule developed at our in...
Show More Location
KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Learn More & Join Trial